RSS   Newsletter   Contact   Advertise with us

Enterprise Therapeutics appoints John Ford as CEO

Staff Writer | Brighton, United Kingdom | October 18, 2016
Enterprise TherapeuticsOctober 18, 2016, Brighton, United Kingdom - Enterprise Therapeutics Ltd, a drug discovery company, announced that it has appointed John Ford as CEO.
Dr. Ford is a successful biotechnology entrepreneur who has co-founded Xention, Ario Pharma and Metrion Biosciences.

Recently, he was a member of the Executive Team at Dezima that is later sold to Amgen in 2015.

Dr. Ford has over 18 years’ ion channel research, drug discovery and drug development experience.

He obtained his BSc and PhD at the University of Leeds, where he worked on the structure and function of TRP channels.

 LATEST MOVES FROM United Kingdom